🔎 Trials Near Me

Beranda › Kanker Kepala dan Leher › Texas › Houston

Uji klinis Kanker Kepala dan Leher di Houston, TX

30 studi untuk Kanker Kepala dan Leher mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)

Menerima pesertaFase 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07101432

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Menerima pesertaFase 2/3
  • Site#0102, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 2
  • The University of Texas MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Menerima pesertaFase 1
  • University of Texas MD Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Menerima pesertaFase 1
  • ALX Center 5, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

Menerima peserta
  • The University of Texas M. D. Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06667427

Intratumoral N17350 in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Menerima pesertaFase 1
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07020117

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Menerima pesertaFase 1
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07462377

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626

IDOV-Immune for Advanced Solid Tumors

Menerima pesertaFase 1
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06910657

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Menerima peserta
  • M D Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT01365169

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Menerima pesertaFase 1/2
  • MD Anderson Cancer Center, Houston
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

Menerima peserta
  • UTHealth Houston Cizik School of Nursing, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06030011

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Menerima pesertaFase 1/2
  • MD Anderson Cancer Center, Houston
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06239194

Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies

Menerima pesertaFase 2
  • M D Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04003051

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Menerima pesertaStudi observasional
  • Md Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT04075305

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Menerima peserta
  • Baylor College of Medicine, Houston
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT07405645

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Menerima peserta
  • Baylor College of Medicine, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT05793151

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Menerima pesertaFase 1/2
  • The University of Texas MD Anderson Cancer Center (site 127), Houston
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Houston
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT05941507

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Menerima pesertaFase 1
  • MD Anderson Cancer Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542

Comprehensive Outcomes for After Cancer Health

Menerima pesertaSukarelawan sehat diterima
  • The University of Texas MD Anderson Cancer Center, Houston
  • UT Health Houston, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2024 · NCT05349227

Uji klinis Kanker Kepala dan Leher di kota lain

Studi lain di Houston

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.